AI-Generated Peptide Targets Rare Blood Disorder in New Research
A paper in Blood Advances describes an AI-designed peptide for platelet-type von Willebrand disease, adding to the growing evidence that AI is accelerating drug discovery for rare conditions.
Subscribe to unlock all stories
Get full access to The Singularity Ledger, archive included.
Cancel anytime. Payments powered by Stripe.